TTLL4
Basic information
Region (hg38): 2:218710835-218755416
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TTLL4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 59 | 62 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 59 | 2 | 4 |
Variants in TTLL4
This is a list of pathogenic ClinVar variants found in the TTLL4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-218737717-G-T | not specified | Uncertain significance (Jan 07, 2022) | ||
2-218737787-G-A | Benign (May 21, 2018) | |||
2-218737788-G-A | not specified | Uncertain significance (Oct 03, 2024) | ||
2-218737817-G-T | Benign (Dec 31, 2019) | |||
2-218737996-C-T | not specified | Uncertain significance (Apr 17, 2024) | ||
2-218738004-G-C | not specified | Uncertain significance (Aug 05, 2024) | ||
2-218738013-A-G | not specified | Uncertain significance (Oct 27, 2023) | ||
2-218738034-C-T | not specified | Uncertain significance (Sep 26, 2023) | ||
2-218738056-C-T | not specified | Uncertain significance (Jun 27, 2022) | ||
2-218738085-C-T | not specified | Uncertain significance (Feb 17, 2023) | ||
2-218738089-C-T | Likely benign (May 24, 2018) | |||
2-218738211-A-G | not specified | Uncertain significance (Nov 18, 2024) | ||
2-218738236-C-T | not specified | Uncertain significance (Feb 02, 2022) | ||
2-218738261-G-T | not specified | Uncertain significance (Dec 13, 2023) | ||
2-218738271-T-C | not specified | Uncertain significance (Dec 03, 2024) | ||
2-218738338-C-G | not specified | Uncertain significance (May 28, 2024) | ||
2-218738404-C-T | not specified | Uncertain significance (Jul 11, 2023) | ||
2-218738418-C-A | not specified | Uncertain significance (Oct 27, 2023) | ||
2-218738484-G-T | not specified | Uncertain significance (Mar 03, 2022) | ||
2-218738533-C-A | not specified | Uncertain significance (Nov 08, 2022) | ||
2-218738544-G-A | not specified | Uncertain significance (Aug 15, 2023) | ||
2-218738623-C-T | not specified | Uncertain significance (Nov 28, 2024) | ||
2-218738668-C-G | not specified | Uncertain significance (Feb 21, 2024) | ||
2-218738679-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
2-218738680-G-A | not specified | Uncertain significance (Oct 26, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TTLL4 | protein_coding | protein_coding | ENST00000392102 | 18 | 44572 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.68e-13 | 1.00 | 125482 | 3 | 263 | 125748 | 0.00106 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.754 | 612 | 667 | 0.918 | 0.0000381 | 7846 |
Missense in Polyphen | 108 | 142.62 | 0.75725 | 1715 | ||
Synonymous | -0.958 | 280 | 260 | 1.08 | 0.0000150 | 2386 |
Loss of Function | 3.45 | 30 | 58.4 | 0.513 | 0.00000345 | 626 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00313 | 0.00313 |
Ashkenazi Jewish | 0.00119 | 0.00119 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.00102 | 0.00102 |
European (Non-Finnish) | 0.00107 | 0.00106 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000196 | 0.000163 |
Other | 0.000660 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Glutamylase which preferentially modifies beta-tubulin and non-tubulin proteins, such as NAP1L1, NAP1L4 and CGAS. Involved in the side-chain initiation step of the polyglutamylation reaction rather than in the elongation step. Involved in formation of short side-chains. Mediates initiation of polyglutamylation of nucleosome assembly proteins NAP1L1 and NAP1L4. Also acts as a monoglutamylase: generates monoglutamylation of CGAS, leading to impair the nucleotidyltransferase activity of CGAS. {ECO:0000250|UniProtKB:Q80UG8}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Carboxyterminal post-translational modifications of tubulin
(Consensus)
Recessive Scores
- pRec
- 0.0937
Intolerance Scores
- loftool
- 0.775
- rvis_EVS
- 1.68
- rvis_percentile_EVS
- 96.34
Haploinsufficiency Scores
- pHI
- 0.166
- hipred
- N
- hipred_score
- 0.372
- ghis
- 0.406
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.108
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Ttll4
- Phenotype
- growth/size/body region phenotype;
Gene ontology
- Biological process
- protein polyglutamylation;peptidyl-glutamic acid modification
- Cellular component
- cytosol;microtubule;cilium
- Molecular function
- ATP binding;tubulin binding;protein-glutamic acid ligase activity;tubulin-glutamic acid ligase activity